Hypera SA stock forecast
Want to see HYPMY full AI Analyst Report?
Hypera SA (HYPMY) Stock Forecast & Price Target
HYPMY Analyst Ratings
HYPMY Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $4.50 | buy | 11.77%Upside | Reiterated | 10/30/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | $4.50 | buy | 11.77%Upside | Reiterated | 10/30/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $4.50 | hold | 11.77%Upside | Downgraded | 10/30/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | $4.50 | hold | 11.77%Upside | Reiterated | 10/30/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $4.50 | hold | 11.77%Upside | Downgraded | 10/30/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $4.50 | buy | 11.77%Upside | Reiterated | 10/30/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | BuyReiterated$4.50 | 10/30/26 | 11.77%Upside | ||
| Google Drug Manufacturers - Specialty and GenericTipRanks - Google | BuyReiterated$4.50 | 10/30/26 | 11.77%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | HoldDowngraded$4.50 | 10/30/26 | 11.77%Upside | ||
| Anthropic Drug Manufacturers - Specialty and GenericTipRanks - Anthropic | HoldReiterated$4.50 | 10/30/26 | 11.77%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldDowngraded$4.50 | 10/30/26 | 11.77%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | BuyReiterated$4.50 | 10/30/26 | 11.77%Upside |
Best Analysts Covering Hypera SA
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -3.50% per trade.
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.60% per trade.
Copying PerPlexity Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.60% per trade.
HYPMY Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, HYPMY has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HYPMY average Analyst price target in the past 3 months is ―.
HYPMY Financial Forecast
HYPMY Earnings Forecast
Next quarter’s earnings estimate for HYPMY is $0.15 with a range of ― to ―. The previous quarter’s EPS was $0.15. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HYPMY Sales Forecast
Next quarter’s sales forecast for HYPMY is $474.15M with a range of ― to ―. The previous quarter’s sales results were $474.15M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
